Arden Trust CO Dexcom Inc Transaction History

Arden Trust CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 14, 2023	SELL	$112.47 - $130.98 $242,260 - $282,130	-2,154 Reduced 44.15%	2,725 $350,000
Q1 2023 Apr 14, 2023	SELL	$104.0 - $122.92 $15,392 - $18,192	-148 Reduced 2.94%	4,879 $566,000
Q4 2022 Jan 20, 2023	SELL	$84.98 - $122.67 $6,203 - $8,954	-73 Reduced 1.43%	5,027 $0
Q3 2022 Oct 20, 2022	SELL	$76.35 - $94.18 $5,802 - $7,157	-76 Reduced 1.47%	5,100 $410,000
Q2 2022 Jul 12, 2022	BUY	$67.99 - $132.89 $275,563 - $538,603	4,053 Added 360.91%	5,176 $385,000
Q1 2022 Apr 11, 2022	BUY	$94.08 - $130.2 $19,004 - $26,300	202 Added 21.93%	1,123 $575,000
Q4 2021 Jan 24, 2022	SELL	$129.87 - $162.82 $2,077 - $2,605	-16 Reduced 1.71%	921 $495,000
Q3 2021 Oct 12, 2021	SELL	$106.71 - $143.18 $11,951 - $16,036	-112 Reduced 10.68%	937 $512,000
Q2 2021 Jul 19, 2021	BUY	$80.99 - $107.93 $84,958 - $113,218	1,049 New	1,049 $448,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Arden Trust CO, based on Form 13F filings with the SEC.

Stay updated on Arden Trust CO with notifications on news.